PRODUCT DETAIL

Everolimus Sandoz 10 mg

Code

1204D

MA number

44/0109/19-S

Product Form:

tbl 30x10 mg (blis.Al/PA/Al/PVC)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

Therapeutic Class:

44 - CYTOSTATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01	ANTINEOPLASTIC AGENTS
L01E	Protein kinase inhibitors
L01EG	Mammalian target of rapamycin (mTOR) kinase inhibitors
L01EG02	Everolimus

Shelf life:

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to restricted medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	16.04.2019
PIL:	PIL_Everolimus Sandoz 10 mg_10.2022.pdf
SPC:	SPC_Everolimus Sandoz 10 mg_01.2023.pdf
Safety feature	Yes
Data update:	12.07.2023